Literature DB >> 3571485

Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.

D K Wagner, D L Nelson, E E Walsh, C B Reimer, F W Henderson, B R Murphy.   

Abstract

Two respiratory syncytial virus glycoproteins, F and G, which differ substantially in the amount of glycosylation were used as antigens in an enzyme-linked immunosorbent assay to determine immunoglobulin G (IgG) subclass titers in 30 experimentally infected healthy adults. The titers of antibodies to the F glycoprotein achieved in postinfection sera were highest in the IgG1 subclass, whereas those to the G glycoprotein were highest and comparable in the IgG1 and IgG2 subclasses. The high IgG2 response to the G glycoprotein suggests that it is seen by the immune system as a polysaccharide antigen, a hypothesis consistent with its large carbohydrate content.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571485      PMCID: PMC266077          DOI: 10.1128/jcm.25.4.748-750.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

2.  Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.

Authors:  E E Walsh; J J Schlesinger; M W Brandriss
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

3.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

Review 5.  Ontogeny of the immune response as a basis of childhood disease.

Authors:  H F Pabst; H W Kreth
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

6.  Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

Authors:  A Morell; B Roth-Wicky; F Skvaril
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion.

Authors:  B F Fernie; J L Gerin
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.

Authors:  D K Wagner; M L Clements; C B Reimer; M Snyder; D L Nelson; B R Murphy
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

10.  The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the O-glycosidically linked oligosaccharides of glycoprotein E1.

Authors:  H Niemann; R Geyer; H D Klenk; D Linder; S Stirm; M Wirth
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  9 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.

Authors:  D K Wagner; P Muelenaer; F W Henderson; M H Snyder; C B Reimer; E E Walsh; L J Anderson; D L Nelson; B R Murphy
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation.

Authors:  G W Wertz; M Krieger; L A Ball
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Immunoglobulin G subclass responses against the structural components of Puumala virus.

Authors:  A Lundkvist; S Björsten; B Niklasson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection.

Authors:  J Huskinson; P N Stepick-Biek; F G Araujo; P Thulliez; Y Suzuki; J S Remington
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G.

Authors:  Kristina Borochova; Katarzyna Niespodziana; Katarina Stenberg Hammar; Marianne van Hage; Gunilla Hedlin; Cilla Söderhäll; Margarete Focke-Tejkl; Rudolf Valenta
Journal:  Vaccines (Basel)       Date:  2020-06-25

Review 7.  Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.

Authors:  Elisabeth A van Erp; Willem Luytjes; Gerben Ferwerda; Puck B van Kasteren
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

8.  Comparative Performance of Recombinant GRA6, GRA7, and GRA14 for the Serodetection of T. gondii Infection and Analysis of IgG Subclasses in Human Sera from the Philippines.

Authors:  Rochelle Haidee Ybañez; Yoshifumi Nishikawa
Journal:  Pathogens       Date:  2022-02-21

9.  The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years.

Authors:  Alfonsina Trento; Rosa Rodríguez-Fernández; María I González-Sánchez; Felipe González-Martínez; Vicente Mas; Mónica Vázquez; Concepción Palomo; José A Melero
Journal:  Front Microbiol       Date:  2017-11-22       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.